Which of these treatment options is primarily used to manage inflammation in Rheumatic fever?

Salicylates are primarily used to manage inflammation in rheumatic fever due to their anti-inflammatory properties. Rheumatic fever often occurs as a complication of untreated streptococcal throat infection and can lead to significant inflammation affecting the heart, joints, and other tissues. The primary aim of treatment is to reduce this inflammation and alleviate symptoms, thereby preventing long-term complications, particularly rheumatic heart disease.

Salicylates, which include aspirin, inhibit the cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins—substances that mediate inflammation and pain. This makes salicylates effective in providing symptomatic relief from the inflammatory processes associated with rheumatic fever.

Other treatment options mentioned, such as stool softeners, thyroid medications, and insulin, are not relevant in this context. Stool softeners are used for constipation, thyroid medications address hormonal imbalances, and insulin is required for glucose management in diabetes. Thus, these options do not target the inflammatory response central to rheumatic fever.